Accession Number: | 0001209191-21-020777 |
Date: | 2021-03-12 |
Issuer: | C4 THERAPEUTICS, INC. (CCCC) |
Original Submission Date: |
DUBIN GLENN
C/O C4 THERAPEUTICS, INC.
490 ARSENAL WAY #200
WATERTOWN, MA 02472
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 44.64 | 2021-03-12 | deemed execution date | A | 41,200 (a) | 2031-03-11 | common stock 41,200 | $44.64 | 41,200 | direct |
ID | footnote |
---|---|
f1 | one-third of this option shall vest and become exercisable on march 12, 2022, with the remainder vesting in eight equal quarterly installments thereafter. |